Screening for Bipolar Disorder in Depression Treatment
Use the Mood Disorder Questionnaire (MDQ) as your first-line screening tool—it takes less than 5 minutes to complete and has the best combination of accuracy and feasibility for busy clinical settings 1, 2.
Why the MDQ is Your Best Choice
The MDQ is a brief self-report instrument that consistently demonstrates good sensitivity (0.73) and very good specificity (0.90) in identifying bipolar spectrum disorders 3. In primary care settings specifically, the MDQ performs with sensitivity of 0.58 and specificity of 0.93, making it particularly useful for ruling in bipolar disorder when positive 2. A cutoff score of 5 or higher provides optimal test accuracy (sensitivity 0.91, specificity 0.67) 1.
When compared head-to-head with the Hypomania Checklist (HCL-32), the MDQ demonstrates superior accuracy and is more practical for clinical use 1. The HCL-32 has lower specificity (0.57) and produces far more false positives—43% of patients screen positive with HCL-32 versus only 8.9% with MDQ 1.
What to Ask: Key Screening Questions
Per guideline recommendations, your screening should focus on 4:
- Distinct, spontaneous periods of mood changes (not just reactions to situations)
- Sleep disturbances associated with mood changes
- Psychomotor activation during these periods
- Personal history of depression (critical context)
- Family history of mood disorders (strong risk factor)
Important caveat: Irritability, reckless behaviors, and increased energy alone lack specificity—they occur in many conditions and should not be used as standalone screening criteria 4.
Why This Matters Clinically
The prevalence of unrecognized bipolar disorder in patients being treated for depression is alarmingly high:
- 21.3% of primary care patients on antidepressants screen positive for bipolar disorder 2
- Nearly two-thirds had never received a bipolar diagnosis 2
- In urban primary care settings, 9.8% screen positive, but only 8.4% report ever being diagnosed 5
- Only 6.5% of those screening positive were taking mood stabilizers 5
Critical Clinical Pitfall
Treating bipolar disorder with antidepressant monotherapy is associated with worse outcomes and delayed accurate diagnosis 6. Patients initially misdiagnosed with MDD and started on antidepressants experience longer times to correct diagnosis compared to those started on mood stabilizers 6. After eventual bipolar diagnosis, these patients show lower rates of guideline-consistent treatment 6.
The Algorithm
- Screen all patients being treated for depression with the MDQ (takes <5 minutes)
- Use a cutoff score of 5 or higher for optimal sensitivity/specificity balance 1
- If MDQ positive: Conduct detailed clinical assessment focusing on episode duration, marked departure from baseline functioning, and impairment across multiple life domains 4
- Verify symptoms represent distinct episodes lasting the required duration per DSM criteria, not just temperamental traits or situational reactions 4
The MDQ is not diagnostic—positive screens require full clinical evaluation, but this simple tool dramatically improves recognition of a commonly missed and potentially dangerous misdiagnosis 5, 7.